Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.39 |
| ▸ | PARP1 | P09874 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.36 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.35 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.35 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.35 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.35 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3548501 | 0.92 | CFD (0.37) | KMT2AMEN1ABCB1PARP1NPC1 | |
| SCHEMBL3548729 | 0.92 | ABCB1 (0.36) | ABCB1PARP1ALDH1A1LMNAABCC1 | |
| SCHEMBL3544102 | 0.91 | ABCB1 (0.42) | KMT2AMEN1ABCB1LMNAABCC1 | |
| SCHEMBL3546929 | 0.87 | HCRTR1 (0.40) | KMT2AMEN1SMN1; SMN2ABCB1KDM4E | |
| SCHEMBL5094562 | 0.86 | CYP26A1 (0.37) | KMT2AMEN1SMN1; SMN2PARP1CYP3A4 | |
| SCHEMBL3543083 | 0.82 | ACHE (0.36) | KMT2AMEN1SMN1; SMN2ABCB1KDM4E | |
| SCHEMBL2795983 | 0.75 | CYP3A4 (0.35) | KMT2AMEN1SMN1; SMN2CYP3A4ALDH1A1 | |
| SCHEMBL3631848 | 0.75 | CYP3A4 (0.35) | KMT2AMEN1SMN1; SMN2CYP3A4ALDH1A1 | |
| SCHEMBL3778768 | 0.73 | LDHA (0.35) | KMT2AMEN1SMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL2794818 | 0.73 | LDHA (0.35) | KMT2AMEN1SMN1; SMN2KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080033007-A1 | Substituted Tetrahydroisoquinoline Compounds for Cancer Therapy | MILLER DUANE D | 2008-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080033007-A1 | Substituted Tetrahydroisoquinoline Compounds for Cancer Therapy | BAD, TP53, MCL1 | KMT2A 1046/4885MEN1 1390/4885SMN1; SMN2 475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.